Cargando…
Immunity and inflammation: the neglected key players in congenital heart disease?
Although more than 90% of children born with congenital heart disease (CHD) survive into adulthood, patients face significantly higher and premature morbidity and mortality. Heart failure as well as non-cardiac comorbidities represent a striking and life-limiting problem with need for new treatment...
Autores principales: | Wienecke, Laura M., Cohen, Sarah, Bauersachs, Johann, Mebazaa, Alexandre, Chousterman, Benjamin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636791/ https://www.ncbi.nlm.nih.gov/pubmed/34855062 http://dx.doi.org/10.1007/s10741-021-10187-6 |
Ejemplares similares
-
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020) -
Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients
por: de Roquetaillade, Charles, et al.
Publicado: (2022) -
Protracted immune disorders at one year after ICU discharge in patients with septic shock
por: Riché, Florence, et al.
Publicado: (2018) -
Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure
por: Lukasz, Alexander, et al.
Publicado: (2013) -
Genetics of Congenital Heart Defects: The NKX2-5 Gene, a Key Player
por: Chung, Ill-Min, et al.
Publicado: (2016)